Drug Type CAR-T |
Synonyms Novel anti CD19 CAR-T cells(Sheba Medical Center) |
Target |
Action modulators |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| CD19 Expressing Malignancies | Phase 2 | Israel | 01 Jun 2026 |





